Literature DB >> 1263440

Cellular aspects of rabbit Masugi nephritis. III. Mesangial changes.

Y Kondo, H Shigematsu, A Okabayashi.   

Abstract

Lytic disarrangement of mesangial matrix was noted in acute proliferative glomerulonephritis induced in the rabbit by injection of duck nephrotoxic antibody. The severity of the change was variable depending upon dose of the antibody injected. With severe mesangiolysis, mesangial areas were highly obscured by marked hypertrophy and proliferation of mesangial cells along with massive infiltration of monocytes into the loosened mesangium and subendothelial space. In addition, there was random mobilization of the mesangial cells as shown by peripheral interposition and intraluminal projection with capillary subdivision. Glomerular capillaries were thus narrowed and distorted. The ultrastructural hallmark of the proliferated mesangial cells was prominence of the Golgi complex and endoplasmic reticulum which suggested accelerated protein synthesis, most likely for repair of the damaged matrix. In the affected glomeruli, exclusive of those undergoing rapid obliteration due to basement membrane rupture, resolution of the acute inflammatory process occurred within 2 weeks. At this stage, two types of glomerular changes became manifest, consisting of: (1) prominent mesangial stalk thickening and cellularity with occasional peripheral interposition of mesangial cells, and (2) segmental capillary subdivisions due to mesangial bridges built between the original mesangium and peripheral loop. It is suggested that chronic glomerular disease may develop based upon these persistent alterations of the glomerular structure. When a smaller dose of the duck antibody was employed, the process was much less prominent and complete recovery from acute glomerulonephritis took place.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1263440

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

1.  Focal mesangial proliferative glomerulonephritis in the rat caused by habu snake venom. A morphologic study.

Authors:  V Cattell; J W Bradfield
Journal:  Am J Pathol       Date:  1977-06       Impact factor: 4.307

2.  Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis.

Authors:  I Shirato; T Sakai; K Kimura; Y Tomino; W Kriz
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

3.  Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injections of monoclonal antibody 1-22-3.

Authors:  H Kawachi; T Iwanaga; S Toyabe; T Oite; F Shimizu
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

4.  Mesangial involvement in hemolytic-uremic syndrome. A light and electron microscopic study.

Authors:  H Shigematsu; S H Dikman; J Churg; E Grishman; J L Duffy
Journal:  Am J Pathol       Date:  1976-11       Impact factor: 4.307

5.  Heparin inhibits mesangial cell proliferation in habu-venom-induced glomerular injury.

Authors:  A K Coffey; M J Karnovsky
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

6.  Severe glomerular mesangiolysis in a patient with rectal adenocarcinoma treated with cytotoxic drugs.

Authors:  G Mazzucco; G Fornari; G Monga
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1982

7.  Rat mesangial cell lysis in vitro is induced by cationic polypeptides.

Authors:  J A Broestl; S N Emancipator
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  Glomerular capillary aneurysms in light-chain nephropathy. An ultrastructural proposal of pathogenesis.

Authors:  R Sinniah; A H Cohen
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

9.  Utilizing methylglyoxal and D-lactate in urine to evaluate saikosaponin C treatment in mice with accelerated nephrotoxic serum nephritis.

Authors:  Chia-Yu Lin; Jen-Ai Lee; Po-Yeh Lin; Shih-Chun Hua; Pei-Yun Tsai; Bi-Li Chen; Chia-En Lin; Tzong-Huei Lee; Shih-Ming Chen
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.